Lirafit Injection
In stock
Description
Lirafit Injection (Liraglutide 6 mg/ml) GLP-1 receptor agonist. It is prescribed alongside diet and exercise to manage type 2 diabetes, prevent cardiovascular events, and aid in weight management.
Specifications
| Drug Class | GLP-1 (glucagon-like peptide-1) receptor agonist |
|---|---|
| Therapeutic Use | Anti-diabetic, metabolic |
| Dosage Form | Solution for Subcutaneous Injection in a Pre-filled Pen |
| Active Ingredient | Liraglutide (recombinant DNA) |
| Target Conditions | Obesity/Weight Management, Cardiovascular Risk Reduction |
